{
  "schemaVersion": 1,
  "id": "research-345",
  "slug": "345-what-human-liver-fractions-revealed-about-slu-pp-332-breakdown",
  "title": "What human liver fractions revealed about SLU-PP-332 breakdown",
  "catalogLabel": "SLU-PP-332",
  "productCollection": "https://heritagebiolabs.com/research-library/products/slu-pp-332",
  "productHandles": [
    "slu-pp-332-707"
  ],
  "productUrls": [
    "https://heritagebiolabs.com/product/slu-pp-332-707"
  ],
  "readingFocus": "Study findings",
  "readingFocusNote": "Reading focus is a navigational tag, not an evidence grade.",
  "wordCount": 262,
  "sourceYears": [
    2023,
    2026
  ],
  "paragraphs": [
    "Peptides are short chains of amino acids joined by peptide bonds. Some can activate receptors that change how cells work. SLU-PP-332 is a small synthetic compound with a different chemical structure from a peptide. It activates a group of proteins called estrogen-related receptors. In 2026, two laboratories examined what happened to the compound when exposed to enzymes prepared from human liver tissue. [1, 2, 3]",
    "Those laboratories used liquid chromatography to separate substances and mass spectrometry to examine the mass and fragments of each signal. One team found nine possible breakdown or transformation products in its tests of SLU-PP-332. Another identified 22 under its experimental conditions. Both studies observed compounds consistent with reactions that add groups to the parent molecule or to products formed earlier. The studies used different experimental workflows and criteria for recognizing the products. A count of detected metabolites depends on what the laboratory is able to produce, separate and measure. [1, 2]",
    "The researchers were interested in chemical markers for testing in sports. A metabolite can sometimes help a laboratory identify exposure after the parent compound has changed. The experiments provide candidate signals and ways to look for them. Establishing which signals occur in a living person would require measurements under different conditions from incubating the material with isolated enzymes. [1, 2]",
    "The word “human” in these papers describes the source of the liver fractions. It does not describe people enrolled in a treatment trial. The studies measured chemical transformations outside the body. They provide no human exercise outcome, safety estimate or evidence of clinical effectiveness. [1, 2]"
  ],
  "sources": [
    {
      "number": 1,
      "citation": "Tristan Möller et al. In Vitro Metabolism and Analytical Characterization of SLU-PP-332 and SLU-PP-915: Novel Pan-ERR Agonists With Doping Potential. Rapid Communications in Mass Spectrometry (publication 2026-04-30).",
      "url": "https://pubmed.ncbi.nlm.nih.gov/41588687/"
    },
    {
      "number": 2,
      "citation": "Nuraly K. Avliyakulov et al. Analysis and Identification of In Vitro Metabolites of Exercise Mimetic SLU-PP-332 ERRα/β/γ Agonist for Doping-Control Purposes. Drug Testing and Analysis (publication 2026-02-13).",
      "url": "https://pubmed.ncbi.nlm.nih.gov/41688415/"
    },
    {
      "number": 3,
      "citation": "Cyrielle Billon et al. Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity. ACS Chemical Biology (publication 2023-03-29).",
      "url": "https://pubmed.ncbi.nlm.nih.gov/36988910/"
    }
  ],
  "canonicalUrl": "https://heritagebiolabs.com/research-library/articles/345-what-human-liver-fractions-revealed-about-slu-pp-332-breakdown",
  "markdownUrl": "https://heritagebiolabs.com/research-library/data/articles/345-what-human-liver-fractions-revealed-about-slu-pp-332-breakdown.md",
  "jsonUrl": "https://heritagebiolabs.com/research-library/data/articles/345-what-human-liver-fractions-revealed-about-slu-pp-332-breakdown.json",
  "provenance": {
    "sourceArchive": "Peptide Research Articles - All 82 Volumes.zip",
    "sourceArchiveSha256": "9796bec477cbe2f8017dda81c7e58260985a13bdda1f934e8eb8d0549c2cada5",
    "sourceVolume": "Peptide Research Articles 069 - Sermorelin and SLU-PP-332.docx",
    "sourceArticleNumber": 345,
    "contentSha256": "8aeb1f3f1b3d7473a648f8b6a1cf0fd6b763fbd4085aca2f8b3f046d1722cfb8",
    "statement": "Article titles, body paragraphs and numbered citations extracted without rewriting from owner-supplied Word volumes. Product mappings use exact catalog labels; reading-focus tags and excerpts are navigational metadata. No independent peer-review or comprehensive source verification is claimed."
  },
  "scope": "Educational article about published research. For research use only; not medical advice. Literature does not establish the identity, purity or activity of a purchased lot, and studies of individual components do not validate a blend."
}
